NDRG2 gene: Miao Zhang et al. (2017) [43] assessed the potential clinical utility of N-Myc downstream-regulated gene 2 (NDRG2), which has been associated with cell differentiation and proliferation, in discriminating bladder cancer in a total of 124 patients who had not received any chemotherapy or radiotherapy before sampling (71 with tumor stage T1–T2 and 45 T3–T4), and 97 healthy controls matched by age and sex. This evidence concerns the gene NDRG2 and urinary bladder carcinoma.